ADIPOQ and obesity disorder: Low levels of adiponectin were positively associated with IR, endothelial dysfunction, and arterial stiffness in people with metabolic disorders such as obesity, MetS, cardiovascular disease (CVD), and type 2 diabetes (T2DM) [8, 11].